MicroRNA-mRNA Regulatory Network Mediates Activation of mTOR and VEGF Signaling in African American Prostate Cancer

Himali Gujrati1, Siyoung Ha1, Azah Mohamed2

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Eastern Shore, Princess Anne, MD 21853, USA.

Insights

Differential microRNA-mRNA networks contribute to prostate cancer (PCa) disparities in African American (AA) men. Targeting these networks may reduce PCa aggressiveness and chemoresistance in AA patients.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • African American (AA) men face higher prostate cancer (PCa) incidence and mortality than European American (EA) men.
  • Socioeconomic factors alone do not fully explain PCa disparities; intrinsic biological differences are implicated.
  • MicroRNA (miRNA)-mRNA regulatory networks are investigated as a potential biological driver of these disparities.

Purpose of the Study:

  • To evaluate the role of differential miRNA-mRNA regulatory networks in promoting PCa disparities between AA and EA men.
  • To identify specific miRNA-mRNA interactions involved in PCa aggressiveness and chemoresistance.

Main Methods:

  • Bioinformatic analysis of miRNA and mRNA expression data.
  • Utilized mirPath V.3 to identify differentially regulated signaling pathways.
  • Validated key miRNA-mRNA interactions using RT-qPCR, miRNA mimics, and antagomirs.
  • Assessed the impact of targeting miRNA-mRNA networks on PCa cell proliferation and chemosensitivity.

Main Results:

  • Identified 58 differentially regulated signaling pathways between AA and EA PCa, focusing on mTOR and VEGF signaling.
  • Discovered 5 reciprocal miRNA-mRNA pairings, including miR-34a-5p/HIF1A, miR-34a-5p/PIK3CB, miR-34a-5p/IGFBP2, miR-99b-5p/MTOR, and miR-96-5p/MAPKAPK2.
  • Experimental validation confirmed regulatory relationships and the impact of targeting these networks on PCa cell behavior and docetaxel sensitivity.

Conclusions:

  • Differential miRNA-mRNA regulatory networks play a significant role in AA PCa disparities.
  • Targeting specific miRNA-mRNA pairings (e.g., via miRNA mimics or antagomirs) can downregulate key oncogenic pathways.
  • Modulating these networks offers a potential therapeutic strategy to reduce PCa aggressiveness and overcome chemoresistance in AA patients.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K